NYLIM
IMGN

New York Life Investment Management’s Immunogen Inc IMGN Stock Holding History

New York Life Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-682,396
Closed -$20.2M – 1578
2023
Q4 		$20.2M Buy
+682,396
New +$13.6M 0.21% 91

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New York Life Investment Management's IMGN Position: Q1 2024 in Review

New York Life Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 682,396 shares — an estimated $20.2M sold.

New York Life Investment Management first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $20.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • New York Life Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 682,396 Immunogen Inc shares in Q1 2024, an estimated $20.2M.
  • New York Life Investment Management first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • New York Life Investment Management's Immunogen Inc position peaked at $20.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.